3.Wei-Lin Wang, Min-Ya Yao, Jing Jin, Chang-Ku Jia, Liang-Hui Gao, Hai-Yang Xie, Shu-Sen Zheng*. Increased expression of non-interleukin-2 T cell growth factors and their implications during liver allograft rejection in the rats；Journal of Gastroenterology and Hepatology. 2007.7(22)；1141-7；ISSN 0815-9319 （IF= 1.875)
4.Wang Weilin, Zhang Guoliang, Wu Lihua, Yao Minya, Jin Jing, Jia Changku, Xie Haiyang, Zhou Lin, Jiang Zhijun, Zheng Shusen. Efficacy of hepatitis B immunoglobulin in relation to the gene polymorphisms of human leukocyte FcγReceptor III (CD16) in Chinese liver transplant patients. Chinese medical Journal. 2007；ISSN 0366-6999 （IF=0.615)
5.Zuozhou Chen, Weilin Wang, Xuefeng Bruce Ling, Jane Jijun Liu, Liangbiao Chen. GO-Diff: Mining functional differentiation between EST-based transcriptomes. BMC Bioinformatics 2006,Feb 16 7:72 doi:10.1186/1471-2105-7-72(IF=5.42)
1471-2105
6.Cheung ST,Tsui TY, Wang WL . Liver as an ideal target for gene therapy: Expression of CTLA4Ig by retroviral gene transfer. J Gantroenterol Hepatol. 2002 Sep;17(9):1008-14
gydjdsj.org.cn7.Xie HY*, Wang WL*, Yao MY, Yu SF, Feng XN, Jin J, Jiang ZJ, Wu LM, Zheng SS.Polymorphisms in cytokine genes and their association with acute rejection and recurrence of hepatitis B in Chinese liver transplant recipients.Arch Med Res. 2008 May;39(4):420-8.（* co-authors)ISSN 0188-4409，IF= 1.772
上一頁 [1] [2] [3] 下一頁
